ULTRAGENYX PHARMACEUTICAL INC. (RARE) DISCUSSES FDA APPROVAL OF GENE THERAPY FOR GLYCOGEN STORAGE DISEASE TYPE 1A TRANSCRIPT - SEEKINGALPHA

FDA approval catalyst for RARE gene therapy targeting glycogen storage disease 1A.